India  
 
NewsR.in

Johnson & Johnson’s 1-shot COVID-19 vaccine shows promise in early-stage trials

Video Credit: WXYZ Detroit - Duration: 04:01s - Published
Johnson & Johnson’s 1-shot COVID-19 vaccine shows promise in early-stage trials

Johnson & Johnson’s 1-shot COVID-19 vaccine shows promise in early-stage trials

Johnson & Johnson’s experimental one-shot vaccine for COVID-19 is showing promising results.

According to recently published data, the vaccine spurred a long-lasting immune response.


You Might Like


Related videos from verified sources

Johnson & Johnson Vaccine May Offer Faster Path to Herd Immunity [Video]

Johnson & Johnson Vaccine May Offer Faster Path to Herd Immunity

Johnson & Johnson's vaccine appears to protect against COVID-19 with just one shot. Not as strong as some rivals but it's still potentially helpful for a world in dire need of more doses. Betty Yu..

Credit: CBS 5 SF KPIX     Duration: 02:09Published
Johnson & Johnson's COVID-19 Vaccine Still Has Advantages Despite Less Effectiveness [Video]

Johnson & Johnson's COVID-19 Vaccine Still Has Advantages Despite Less Effectiveness

Overall, Johnson & Johnson's vaccine is 85% effective in preventing severe disease with a single shot.

Credit: CBS 11 Dallas     Duration: 02:10Published
In-depth: New data on Johnson & Johnson COVID-19 vaccine [Video]

In-depth: New data on Johnson & Johnson COVID-19 vaccine

Johnson and Johnson says its single-shot vaccine provides strong protection against severe cases of COVID-19, but it is somewhat less effective overall than the two mRNA vaccines currently in use.

Credit: ABC 10 News | San Diego     Duration: 03:24Published